articles about vaccine in Abstracts

The study further emphasized the vast evolutionary capacity of swine IAV, under natural infection and vaccination pressure scenarios.

This technology could benefit commercial pig production while providing an enriched behavioral environment.

These findings provide deep insights into the molecular characteristics, genetic diversity, pathogenicity, antigenicity, and evolution of CSFV strains in Vietnam.

Approaches to ASF vaccinology and the key constraints involved in the scale-up and commercialization of vaccine candidates.

This study demonstrated the presence of multiple PRRSV lineages, sub-lineages, and variants in swine herds and its potential association with swine reproductive performance under field conditions.

The study assessed whether vaccines administered to the uterus at breeding can lead to sufficient colostral antibodies to protect suckling piglets against PEDV.

The thermostability of lyophilized live-attenuated CSFV vaccine formulations were investigated.

Vaccine candidate ASFV-G-ΔI177L is able to induce protection against virulent Vietnamese ASFV field strains.

EpiCC thresholds can be evaluated for predictive accuracy of protection in future efficacy studies.

Vaccinating against the influenza A (H1N1)pdm09 virus, can improve reproductive performance in sow herds infected with pandemic influenza A virus.

The gene-deleted HLJ/-18-7GD virus is a safe and effective vaccine against ASFV, and could play an important role in controlling the spread of ASFV.

This is, to our knowledge, the first report of a promising vaccine against ASF virus in wild boar by oral administration.

The efficacy of the attenuated PRRSV-1 vaccine in 1-day-old pigs seropositive to PRRSV prior to a PRRSV-1 challenge was demonstrated by improvement of clinical, virological and immunological variables.

This study assessed the efficacy of two different Mycoplasma hyopneumoniae vaccination programmes in relation to the time of weaning.

The purpose of the study was to evaluate the effect of vaccination against PCV2 in a sub-clinically infected, high-health finishing herd in terms of viral load in serum, feed conversion ratio and antimicrobial treatments.

The development of piglet immune system under vaccination against PRRSV it is not improved by the use of probiotics and prebiotics or colostrum.